CONMED Corp Insider Trading for February 2021
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in CONMED Corp.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in CONMED Corp for February 2021.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 23 2021 | CNMD | CONMED CORP | TRYNISKI MARK E | Director | Sell | S | 122.23 | 3,400 | 415,582 | 42,889 | 46.3 K to 42.9 K (-7.35 %) |
Feb 23 2021 | CNMD | CONMED CORP | TRYNISKI MARK E | Director | Sell | S | 122.05 | 90 | 10,985 | 46,289 | 46.4 K to 46.3 K (-0.19 %) |
Feb 19 2021 | CNMD | CONMED CORP | Hartman Curt R | President, CEO and ... | Sell | S | 120.68 | 3,100 | 374,108 | 122,857 | 126 K to 122.9 K (-2.46 %) |
Feb 19 2021 | CNMD | CONMED CORP | Hartman Curt R | President, CEO and ... | Sell | S | 119.73 | 11,900 | 1,424,787 | 125,957 | 137.9 K to 126 K (-8.63 %) |
Feb 18 2021 | CNMD | CONMED CORP | TRYNISKI MARK E | Director | Option Exercise | M | 41.06 | 7,195 | 295,427 | 0 | |
Feb 18 2021 | CNMD | CONMED CORP | TRYNISKI MARK E | Director | Option Exercise | M | 55.70 | 1,000 | 55,700 | 0 | |
Feb 18 2021 | CNMD | CONMED CORP | TRYNISKI MARK E | Director | Option Exercise | M | 39.64 | 1,000 | 39,640 | 0 | |
Feb 18 2021 | CNMD | CONMED CORP | TRYNISKI MARK E | Director | Option Exercise | M | 32.93 | 1,000 | 32,930 | 0 | |
Feb 18 2021 | CNMD | CONMED CORP | TRYNISKI MARK E | Director | Option Exercise | M | 26.09 | 1,000 | 26,090 | 0 | |
Feb 18 2021 | CNMD | CONMED CORP | TRYNISKI MARK E | Director | Option Exercise | M | 27.63 | 1,000 | 27,630 | 0 | |
Feb 18 2021 | CNMD | CONMED CORP | TRYNISKI MARK E | Director | Sell | S | 121.31 | 2,545 | 308,734 | 46,379 | 48.9 K to 46.4 K (-5.20 %) |
Feb 18 2021 | CNMD | CONMED CORP | TRYNISKI MARK E | Director | Sell | S | 120.88 | 2,230 | 269,562 | 48,924 | 51.2 K to 48.9 K (-4.36 %) |
Feb 18 2021 | CNMD | CONMED CORP | TRYNISKI MARK E | Director | Payment of Exercise | F | 122.10 | 2,420 | 295,482 | 51,154 | 53.6 K to 51.2 K (-4.52 %) |
Feb 18 2021 | CNMD | CONMED CORP | TRYNISKI MARK E | Director | Buy | M | 41.06 | 7,195 | 295,427 | 53,574 | 46.4 K to 53.6 K (+15.51 %) |
Feb 18 2021 | CNMD | CONMED CORP | TRYNISKI MARK E | Director | Payment of Exercise | F | 120.69 | 462 | 55,759 | 46,379 | 46.8 K to 46.4 K (-0.99 %) |
Feb 18 2021 | CNMD | CONMED CORP | TRYNISKI MARK E | Director | Buy | M | 53.83 | 1,000 | 53,830 | 46,841 | 45.8 K to 46.8 K (+2.18 %) |
Feb 18 2021 | CNMD | CONMED CORP | TRYNISKI MARK E | Director | Payment of Exercise | F | 120.69 | 329 | 39,707 | 45,841 | 46.2 K to 45.8 K (-0.71 %) |
Feb 18 2021 | CNMD | CONMED CORP | TRYNISKI MARK E | Director | Buy | M | 39.64 | 1,000 | 39,640 | 46,170 | 45.2 K to 46.2 K (+2.21 %) |
Feb 18 2021 | CNMD | CONMED CORP | TRYNISKI MARK E | Director | Payment of Exercise | F | 120.69 | 273 | 32,948 | 45,170 | 45.4 K to 45.2 K (-0.60 %) |
Feb 18 2021 | CNMD | CONMED CORP | TRYNISKI MARK E | Director | Buy | M | 32.93 | 1,000 | 32,930 | 45,443 | 44.4 K to 45.4 K (+2.25 %) |
Feb 18 2021 | CNMD | CONMED CORP | TRYNISKI MARK E | Director | Payment of Exercise | F | 120.69 | 217 | 26,190 | 44,443 | 44.7 K to 44.4 K (-0.49 %) |
Feb 18 2021 | CNMD | CONMED CORP | TRYNISKI MARK E | Director | Buy | M | 26.09 | 1,000 | 26,090 | 44,660 | 43.7 K to 44.7 K (+2.29 %) |
Feb 18 2021 | CNMD | CONMED CORP | TRYNISKI MARK E | Director | Payment of Exercise | F | 120.69 | 229 | 27,638 | 43,660 | 43.9 K to 43.7 K (-0.52 %) |
Feb 18 2021 | CNMD | CONMED CORP | TRYNISKI MARK E | Director | Buy | M | 27.63 | 1,000 | 27,630 | 43,889 | 42.9 K to 43.9 K (+2.33 %) |